CD8A and melanoma: In an early study, vaccination with a cocktail of 12 melanoma peptides restricted by class I HLA molecules (12MPs) plus a tetanus toxoid helper peptide induced CD8+ cell response to these 12MPs in 100% of treated patients [87].